Literature DB >> 11319313

Assessment of fatigue and psychologic disturbances in patients with hepatitis C virus infection.

J Obhrai1, Y Hall, B S Anand.   

Abstract

BACKGROUND: It is a common clinical impression that fatigue is a frequent, and often debilitating, symptom in patients with chronic hepatitis C virus (HCV) infection. However, despite its obvious clinical importance, several aspects of fatigue, including its relationship with the underlying liver disease and the presence of psychologic disturbances, have not been well examined. GOALS: The current study was carried out to assess these issues. STUDY: A total of 149 subjects were included in the study and were assigned to one of the following study groups: healthy controls (31), chronic HCV infection (24), combined HCV infection and chronic alcohol abuse (32), alcoholic liver disease (22), and chronic non-liver diseases (40). All subjects were administered investigator-assisted questionnaires designed to analyze the presence and severity of fatigue and psychologic abnormalities.
RESULTS: The mean (+/-SD) fatigue scores in patients with chronic HCV infection (140 +/- 22.9; p = 0.002), alcoholic liver disease (127 +/- 31.4; p < 0.001), mixed (HCV/alcoholic) liver disease (131 +/- 29.0; p < 0.001), and chronic non-liver diseases (128 +/- 35.9; p = 0.004) were significantly greater compared to with healthy subjects (101 +/- 31.8). The total fatigue scores were higher in HCV-infected subjects compared with the other patient groups, but the differences failed to reach statistical significance. Moreover, the fatigue experienced by patients with HCV did not improve with rest as effectively as in the other study groups. All patient groups had higher scores for psychologic disturbances compared with healthy subjects.
CONCLUSIONS: The current study shows that fatigue and psychologic disturbances occur frequently in chronic diseases. The fatigue experienced by patients with HCV infection is more severe and intransigent and responds poorly to relieving factors. Moreover, patients with HCV infection are more depressed and harbor greater feelings of anger and hostility compared with those with non-liver chronic diseases. These observations are important because proper management of the psychologic symptoms may have a favorable impact on the quality of life of patients with HCV infection.

Entities:  

Mesh:

Year:  2001        PMID: 11319313     DOI: 10.1097/00004836-200105000-00011

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  20 in total

Review 1.  The impact of liver disease on health-related quality of life: a review of the literature.

Authors:  Lisa M Martin; Michael J Sheridan; Zobair M Younossi
Journal:  Curr Gastroenterol Rep       Date:  2002-02

2.  Symptom distress in patients with end-stage liver disease toward the end of life.

Authors:  Lissi Hansen; Michael C Leo; Michael F Chang; Atif Zaman; Willscott Naugler; Jonathan Schwartz
Journal:  Gastroenterol Nurs       Date:  2015 May-Jun       Impact factor: 0.978

3.  Somatic symptoms and the association between hepatitis C infection and depression in HIV-infected patients.

Authors:  Jeanie C Yoon; Paul K Crane; Paul S Ciechanowski; Robert D Harrington; Mari M Kitahata; Heidi M Crane
Journal:  AIDS Care       Date:  2011-05-23

4.  Sustained viral response to pegylated interferon alpha-2b and ribavirin in chronic hepatitis C refractory to prior treatment.

Authors:  A Mathew; L P Peiffer; K Rhoades; T McGarrity
Journal:  Dig Dis Sci       Date:  2006-09-27       Impact factor: 3.199

5.  Hepatitis C and poor quality of life: is it the virus or the patient?

Authors:  Ayman A Abdo
Journal:  Saudi J Gastroenterol       Date:  2008-07       Impact factor: 2.485

Review 6.  Role of the psychiatrist in the care of patients with hepatitis C and HIV/AIDS.

Authors:  Stephen Price; Juanita Goyette
Journal:  Psychiatr Q       Date:  2003

7.  The impact of chronic hepatitis C and co-morbid illnesses on health-related quality of life.

Authors:  Jeffrey W Kwan; Ruth C Cronkite; Antony Yiu; Mary K Goldstein; Lewis Kazis; Ramsey C Cheung
Journal:  Qual Life Res       Date:  2008-04-22       Impact factor: 4.147

8.  Uncertainty, symptoms, and quality of life in persons with chronic hepatitis C.

Authors:  Donald E Bailey; Lawrence Landerman; Julie Barroso; Patricia Bixby; Merle H Mishel; Andrew J Muir; Lisa Strickland; Elizabeth Clipp
Journal:  Psychosomatics       Date:  2009 Mar-Apr       Impact factor: 2.386

Review 9.  Cognitive dysfunction in chronic hepatitis C: a review.

Authors:  William Perry; Robin C Hilsabeck; Tarek I Hassanein
Journal:  Dig Dis Sci       Date:  2007-08-17       Impact factor: 3.199

10.  Design of the PEDS-C trial: pegylated interferon +/- ribavirin for children with chronic hepatitis C viral infection.

Authors:  Karen F Murray; James R Rodrigue; Regino P González-Peralta; John Shepherd; Bruce A Barton; Patricia R Robuck; Kathleen B Schwarz
Journal:  Clin Trials       Date:  2007       Impact factor: 2.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.